These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 3839112)
41. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice. Chow EC; Quach HP; Vieth R; Pang KS Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451 [TBL] [Abstract][Full Text] [Related]
42. Effects of vitamin D deprivation and 1,25-dihydroxyvitamin D3 treatment on ion release from rat tibiae in vitro. Ramp WK; Toverud SU; Boass A Bone Miner; 1986 Feb; 1(1):1-13. PubMed ID: 3508714 [TBL] [Abstract][Full Text] [Related]
43. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
44. Stimulation of neonatal mouse calvarial bone resorption by the glucocorticoids hydrocortisone and dexamethasone. Conaway HH; Grigorie D; Lerner UH J Bone Miner Res; 1996 Oct; 11(10):1419-29. PubMed ID: 8889841 [TBL] [Abstract][Full Text] [Related]
45. Ion microprobe analysis of mouse calvariae in vitro: evidence for a "bone membrane". Bushinsky DA; Chabala JM; Levi-Setti R Am J Physiol; 1989 Jan; 256(1 Pt 1):E152-8. PubMed ID: 2912140 [TBL] [Abstract][Full Text] [Related]
47. Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariae. al-Humidan A; Ralston SH; Hughes DE; Chapman K; Aarden L; Russell RG; Gowen M J Bone Miner Res; 1991 Jan; 6(1):3-8. PubMed ID: 2048428 [TBL] [Abstract][Full Text] [Related]
48. Effects in vivo of vitamin D metabolites and 17 beta-estradiol on parathyroid hormone-dependent formation of adenosine 3',5'-monophosphate in rat bone. Marcus R; Orner FB; Brickman AS Endocrinology; 1980 Nov; 107(5):1593-9. PubMed ID: 6253269 [TBL] [Abstract][Full Text] [Related]
49. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo. Reinhardt TA; Horst RL Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926 [TBL] [Abstract][Full Text] [Related]
50. Constitutive expression of osteoclast-stimulating activity by normal clonal osteoblast-like cells: effects of parathyroid hormone and 1,25-dihydroxyvitamin D3. Collin P; Guenther HL; Fleisch H Endocrinology; 1992 Sep; 131(3):1181-7. PubMed ID: 1505460 [TBL] [Abstract][Full Text] [Related]
51. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone. van Leeuwen JP; Birkenhäger JC; van den Bemd GC; Pols HA Biochim Biophys Acta; 1996 Jun; 1312(1):54-62. PubMed ID: 8679716 [TBL] [Abstract][Full Text] [Related]
53. Intact insulin-like growth factor binding protein-5 (IGFBP-5) associates with bone matrix and the soluble fragments of IGFBP-5 accumulated in culture medium of neonatal mouse calvariae by parathyroid hormone and prostaglandin E2-treatment. Hakeda Y; Kawaguchi H; Hurley M; Pilbeam CC; Abreu C; Linkhart TA; Mohan S; Kumegawa M; Raisz LG J Cell Physiol; 1996 Feb; 166(2):370-9. PubMed ID: 8591997 [TBL] [Abstract][Full Text] [Related]
54. Effect of 1,25-dihydroxyvitamin D3 on prostaglandin E2 production in cultured mouse parietal bones. Klein-Nulend J; Pilbeam CC; Raisz LG J Bone Miner Res; 1991 Dec; 6(12):1339-44. PubMed ID: 1838853 [TBL] [Abstract][Full Text] [Related]
55. Regulation of messenger ribonucleic acid expression of 1 alpha,25-dihydroxyvitamin D3-24-hydroxylase in rat osteoblasts. Nishimura A; Shinki T; Jin CH; Ohyama Y; Noshiro M; Okuda K; Suda T Endocrinology; 1994 Apr; 134(4):1794-9. PubMed ID: 8137744 [TBL] [Abstract][Full Text] [Related]
56. Metabolic, but not respiratory, acidosis increases bone PGE(2) levels and calcium release. Bushinsky DA; Parker WR; Alexander KM; Krieger NS Am J Physiol Renal Physiol; 2001 Dec; 281(6):F1058-66. PubMed ID: 11704556 [TBL] [Abstract][Full Text] [Related]
57. In vitro studies on bone resorption in neonatal mouse calvariae using a modified dissection technique giving four samples of bone from each calvaria. Ljunggren O; Ransjö M; Lerner UH J Bone Miner Res; 1991 Jun; 6(6):543-50. PubMed ID: 1887817 [TBL] [Abstract][Full Text] [Related]
58. Response to parathyroid hormone and 1,25-dihydroxyvitamin D3 of bone-derived cells isolated from normal children and children with abnormalities in skeletal development. Silve C; Grosse B; Tau C; Garabedian M; Fritsch J; Delmas PD; Cournot-Witmer G; Balsan S J Clin Endocrinol Metab; 1986 Mar; 62(3):583-90. PubMed ID: 3003145 [TBL] [Abstract][Full Text] [Related]
59. Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development. Xue Y; Karaplis AC; Hendy GN; Goltzman D; Miao D Hum Mol Genet; 2005 Jun; 14(11):1515-28. PubMed ID: 15843402 [TBL] [Abstract][Full Text] [Related]
60. Bone resorption and response to calcium-regulating hormones in the absence of tissue or urokinase plasminogen activator or of their type 1 inhibitor. Leloup G; Lemoine P; Carmeliet P; Vaes G J Bone Miner Res; 1996 Aug; 11(8):1146-57. PubMed ID: 8854251 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]